Provided by Tiger Fintech (Singapore) Pte. Ltd.

Jasper Therapeutics

2.28
+0.10004.59%
Post-market: 2.27-0.0100-0.44%19:12 EDT
Volume:241.65K
Turnover:546.42K
Market Cap:63.67M
PE:-0.38
High:2.33
Open:2.22
Low:2.20
Close:2.18
52wk High:26.05
52wk Low:2.16
Shares:27.92M
Float Shares:22.81M
Volume Ratio:0.51
T/O Rate:1.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0237
EPS(LYR):-4.8865
ROE:-146.87%
ROA:-73.30%
PB:2.71
PE(LYR):-0.47

Loading ...

Feb 12, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 09, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 06, 2024

Major Issues Report

Form 8-K - Current report
Feb 05, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 02, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 04, 2024

Major Issues Report

Form 8-K - Current report
Jan 02, 2024

Major Issues Report

Form 8-K - Current report
Dec 20, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2023

Major Issues Report

Form 8-K - Current report
Oct 20, 2023

Major Issues Report

Form 8-K - Current report
Oct 13, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 10, 2023

Major Issues Report

Form 8-K - Current report
Oct 10, 2023

Major Issues Report

Form 8-K - Current report
Oct 10, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 25, 2023

Major Issues Report

Form 8-K - Current report
Sep 21, 2023

Major Issues Report

Form 8-K - Current report
Aug 12, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2023

Major Issues Report

Form 8-K - Current report